ʻO Peptide Custom Synthesis 7-La Hoʻouna

Hāʻawi i nā ala noiʻi hiki ke kūpono no
ʻepekema peptide
Keena hoʻomaʻemaʻe maʻemaʻe
0 Papa
Nā kaʻina hana a hiki i 100AA
0 AA
Hui hoʻololi peptide 300+
0 +
E koho mai ka palau a i 99% ka maemae.
0 +

Nā lawelawe a me nā huahana

Hoʻopili ʻia ʻo Peptide Synthesis

· 99% maʻemaʻe
· Mai ka mg-kg
· Nā kaʻina hana maʻamau a hiki i 200AA

ʻO nā peptide hoʻonani

· Tripeptide-1;GHK-Cu
· Acetyl hexapeptide-8
· paʻi-8;AHK- Cu

Catalog Peptide

· Antigen Peptides
· Antimicrobial Peptides
· Peptide Kuʻi Kelepona

Hoʻololi

· Kaumaha ʻia ka isotope kaumaha
·C-terminal; N-terminal
.ʻO Glycopeptides;Cyclic Peptide

Lepili peptide

· Biotinylation
· Hoʻopaʻa ʻia ʻo Fluorescent
· Mea hōʻailona Antibody

Peptide CRO

· Hoʻolālā a me ka Synthesis
· Ka Hoʻomohala Hana
· Kākoʻo ʻenehana

peptide hoao

·MS;HPLC;PH
· Maʻemaʻe; Maʻiʻo
· Endotoxin

Pehea e hana maikaʻi ai

Papa 100 lumi hoʻomaʻemaʻe

Mai ka ʻanuʻu mua i ka hoʻomaka ʻana o ka hoʻokolohua a i ka pae hope o ka hoʻopili ʻana, mālama mau ʻia i loko o kahi ʻano ʻino a hoʻomaʻemaʻe ʻia.

ʻIke ʻakomi a hoʻoponopono: Ka hoʻopaʻa ʻana; kaomi ea; haʻahaʻa; mahana wela; hopu ʻia nā ʻāpana lepo a hoʻoponopono ʻia.

Pūʻulu ʻenehana Organic a me Biological Dual Domain

Hele mai kā mākou mau ʻenehana mai ka ʻoihana kemika a me ka biology, a ua akamai i nā ʻano hana peptide synthesis, me ka peptide synthesis paʻa, ka hoʻoheheʻe ʻana o ka peptide wai, hui pū ʻia ka wai-paʻa peptide synthesis, ka hoʻohui ʻana i ka peptide ʻano paʻa paʻa, a me ka fermentation microbial.

Ka hoomalu maikai: ʻO ka nānā ʻana iā ʻoe iho ma ke ʻano he kumu no ka hoʻolaha ʻana i ka hana.

ʻO ka lawe ʻana i ka ʻike mua ma ke ʻano he mea noʻonoʻo a noʻonoʻo ʻaʻole hiki ke hoʻoholo i kēlā me kēia kaʻina hana, ua lilo ia i code of conduct e hoʻomau i ka hoʻāʻo pinepine ʻana i kēlā me kēia kaʻina hana a e hoʻokele i ke kaʻina hana aʻe me ka ʻikepili maoli ma ke ʻano he hōʻike kākoʻo., ʻo ia hoʻi ka nānā ʻana i nā ʻāpana i loko o ke kaiapuni; haʻahaʻa; mahana wela; kaomi; a me ka maemae; maʻiʻo; endotoxin; Waiwai PH; sterility i ka hana, a pela aku.

Nā lako hana: peptide synthesis i ka lyophilization, mai mg a i kg

Mai ka mg o nā peptides maʻamau no ka noiʻi ʻepekema i kg o nā peptides cosmetic, Loaʻa iā mākou nā lako kikoʻī a pau mai ka synthesis; ka hoomaemae ana; hoomakaukau ana; lyophilization; hoao ana.

ʻIkepili Frontier

E hahai i kā mākou mau hana ʻenehana hou loa a me ka ʻike ʻokiʻoki i ke kahua peptide.

Why Menarini’s European GLP-1 Deal Matters for Peptide Innovators

Why Menarini’s European GLP-1 Deal Matters for Peptide

Discovery: where manufacturability is decided Licensing tends to surface a discovery-stage reality that gets skimmed over when a molecule is stillonly

How Oral GLP-1 Rewrites the Peptide Development Brief

How Oral GLP-1 Rewrites the Peptide Development Brief

Why Oral Delivery Reshapes the Development Mandate An orally delivered peptide must survive conditions an injectable never encounters. The gastrointestinal tract presents

From Mouse Longevity Claims to Human Trials: A Peptide Evidence-Assessment Framework

From Mouse Longevity Claims to Human Trials: A…

Structure of the Evidence Betweenintriguing mouse findingandclinical conclusionsit measurable attrition points that do not depend on which peptide

Hoʻokaʻaʻike a me ke kōkua

E nīnau mai iā mākou i kekahi mea ma ke kahua peptide.

E kelepona i kahi loea peptide

E kamaʻilio wikiwiki ma o whatsapp a i ʻole e hoʻouna i kāu mau pono a me nā nīnau ma o ka palapala.

FAQ

E nānā i kā mākou FAQ no ka loaʻa wikiwiki o ka ʻike.

Home Huli Whatsapp Nā lawelawe Huahana